However, KAT2B was shown as a positive co-factor of the Hedgehog–Gli signaling pathway in brain tumors, and KAT2B silencing attenuated the tumor-forming capacity of neural stem cells in vivo [64], suggesting that the KAT2B role in stem cell biology might be highly context-dependent. The gene discussed is KAT2B; the disease is brain neoplasm.